5 Stocks With Massive Upside Potential Backed by Billionaires and Analysts

Discover 5 high-upside stocks gaining attention from billionaires and top analysts. These picks could be tomorrows breakout winners.

May 10 2025

As we head into the weekend, it's the perfect time to uncover hidden gems that top analysts and billionaire investors believe have serious upside potential. Whether you're into large caps like $ADBE or small caps like $CRMD and $ASTS, the table is set for a potentially strong run. Here's what the data says:

$ADBE Adobe Inc.

Billionaire Backing: Bruce Kovner & Paul Tudor Jones

At $383.28, Adobe looks heavily discounted from its 52-week high of $587.75. Despite a sideways trend, its fundamentals remain strong with a PE ratio of 25.26 and EPS of 15.17. The RSI at 56.70 suggests room to run before hitting overbought levels. Trading below all major moving averages, it’s a value play that top hedge funds are quietly accumulating.

$ASTS AST SpaceMobile Inc.

Billionaire Backing: David E. Shaw

At $25.76 and up 2.02% Friday, ASTS continues to attract speculative buyers. It’s a moonshot small-cap with massive 52-week range from $2.13 to $39.07. With a beta of 2.05 and RSI near 55, the stock is volatile but alive. Expect fireworks if the market regains risk-on momentum.

$BA Boeing Co.

Analyst Price Target Upgrade from UBS

Closing at $194.85, Boeing is flirting with its 52-week high of $196.95. Momentum is firmly in its favor with a strong RSI of 72.12 and a confirmed uptrend. The UBS target boost highlights confidence in the stock navigating geopolitical risks. It's one of the few legacy industrials flashing near-term strength.

$CRMD CorMedix Inc.

Bullish Earnings Revisions

CorMedix is making waves on the back of surging earnings estimates. At $11.66, it’s up big from its 52-week low of $3.61 and sporting a healthy RSI of 71.96. Volume has exploded recently, and analysts are warming up. If estimates hold, this small-cap biotech could rally fast.

$CRDO Credo Technology Group

Backed by Billionaire David E. Shaw

Despite a modest pullback to $50.80, the long-term narrative remains intact. It’s still up big from its $17.17 low. Credo has extreme valuation metrics, including a PE ratio above 3,000, but strong institutional backing makes it a potential breakout tech name.

Bottom Line: Who Offers the Most Attractive Near-Term Opportunity?

While $BA shines with immediate technical strength and analyst backing, the most asymmetric upside lies in $CRMD, given the combination of bullish earnings revisions, high volume, and a strong technical recovery. For those favoring blue-chip safety, $ADBE is an attractive contrarian bet, backed by billionaires and trading at a steep discount.

Unlock Exclusive Stock Insights!

Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.

Signup now for FREE and stay ahead of the market curve!

Why Join?

Find out what 10,000+ subscribers already know.

Real-time insights for informed decisions.

Limited slots available, SignUp Now!

Signup Now!

Please note that the article should not be considered as investment advice or marketing, and it does not take into account the personal data and requirements of any individual. It is not a substitute for the reader's own judgment, and it should not be considered as advice or recommendation for buying or selling any securities or financial products.